Tongji Hospital: Carcinoma, Ovarian Epithelial trials

The registry lists 10 Carcinoma, Ovarian Epithelial studies with Tongji Hospital as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 3Phase 3 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian CancerNot yet recruitingNCT06990516Phase 1/2
• SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian CancerNot yet recruitingNCT06990503Phase 3
• A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the OvaryRecruitingNCT06279104
• Safety and Efficacy of KM1 in Subjects With Recurrent or Refractory Ovarian CancerRecruitingNCT05684731Phase 1
• A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian CancerRecruitingNCT05206890
• A Biomarker Exploration Study of Precision Treatment in Ovarian CancerActive, not recruitingNCT06483425
• Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian CancerCompletedNCT06385912
• Biomarker-driven Targeted Therapy in Patients With Recurrent Platinum-resistant Epithelial Ovarian CancerCompletedNCT05044871Phase 2
• Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian CancerActive, not recruitingNCT04507841Phase 2
• Detection of Ovarian Cancer Using an Artificial Intelligence Enabled Transvaginal Ultrasound Imaging AlgorithmStatus unknownNCT04214782Not applicable